Pages that link to "Q34358895"
Jump to navigation
Jump to search
The following pages link to Outcome of patients hospitalized for complications after outpatient liver biopsy (Q34358895):
Displaying 50 items.
- Guidelines on the use of liver biopsy in clinical practice (Q22306550) (← links)
- Indications, methods, and outcomes of percutaneous liver biopsy in England and Wales: an audit by the British Society of Gastroenterology and the Royal College of Physicians of London (Q24541328) (← links)
- State-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectives (Q28085479) (← links)
- Use of fibrin sealant to reduce bleeding after needle liver biopsy in an anticoagulated canine model: work in progress (Q30303955) (← links)
- ARFI elastography in patients with chronic autoimmune liver diseases: A preliminary study (Q30454106) (← links)
- Real-time elastography as a noninvasive technique for quantification of fibrosis in patients with chronic viral liver disease: Preliminary findings (Q30454108) (← links)
- Transient elastography: Kill two birds with one stone? (Q30454363) (← links)
- Complications after interventional sonography of focal liver lesions: a 22-year single-center experience. (Q30884625) (← links)
- 3D Multiecho Dixon for the Evaluation of Hepatic Iron and Fat in a Clinical Setting (Q31164876) (← links)
- Coagulation defects in cirrhosis--old dogmas not yet ready for burial (Q33371759) (← links)
- Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial (Q33389011) (← links)
- Percutaneous liver biopsy after living donor liver transplantation resulting in fulminant hepatic failure: the first reported case of hepatic compartment syndrome (Q33781247) (← links)
- Mechanisms of tissue-iron relaxivity: nuclear magnetic resonance studies of human liver biopsy specimens. (Q33944316) (← links)
- Magnetic resonance imaging measurement of iron overload (Q33944366) (← links)
- The role of the interventional radiologist. Transjugular procedures. (Q34139693) (← links)
- Liver biopsy: when, how, by whom, and where? (Q34140807) (← links)
- Liver biopsy in a district general hospital: changes over two decades (Q34225745) (← links)
- Is day case liver biopsy underutilised? (Q34409043) (← links)
- Cost-effectiveness of ultrasound-guided liver biopsy (Q34467539) (← links)
- Liver biopsy for histological assessment: The case against (Q34469006) (← links)
- Liver biopsy for histological assessment: The case in favor (Q34469014) (← links)
- The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. (Q34557669) (← links)
- Decreases in molecular diffusion, perfusion fraction and perfusion-related diffusion in fibrotic livers: a prospective clinical intravoxel incoherent motion MR imaging study (Q34600947) (← links)
- Relaxivity‐iron calibration in hepatic iron overload: Probing underlying biophysical mechanisms using a Monte Carlo model (Q34731198) (← links)
- The factors associated with longitudinal changes in liver stiffness in patients with chronic hepatitis B. (Q35231817) (← links)
- Use of pethidine for percutaneous liver biopsy - a randomised, placebo-controlled, double blind study (Q35379928) (← links)
- Controversies in liver biopsy: who, where, when, how, why? (Q35628105) (← links)
- Methotrexate and psoriasis in the era of new biologic agents (Q35630761) (← links)
- Outpatient blind percutaneous liver biopsy in infants and children: is it safe? (Q35733523) (← links)
- Quantitative liver function tests improve the prediction of clinical outcomes in chronic hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis trial (Q35818743) (← links)
- Safety and effectiveness of blind percutaneous liver biopsy: analysis of 1412 procedures (Q35819904) (← links)
- Liver biopsy in patients with inherited disorders of coagulation and chronic hepatitis C. (Q35882760) (← links)
- Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update (Q36156172) (← links)
- Assessment of transient elastography (FibroScan) for diagnosis of fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis (Q36229944) (← links)
- Raman spectroscopy using plasmonic and carbon-based nanoparticles for cancer detection, diagnosis, and treatment guidance.Part 1: Diagnosis. (Q36298664) (← links)
- Liver T1ρ MRI measurement in healthy human subjects at 3 T: a preliminary study with a two-dimensional fast-field echo sequence (Q36365476) (← links)
- A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C. (Q37090659) (← links)
- Evaluating the risk of hepatocellular carcinoma in patients with prominently elevated liver stiffness measurements by FibroScan: a multicentre study (Q37149657) (← links)
- Safety, Utilization, and Cost of Image-Guided Percutaneous Liver Biopsy Among Cancer Patients (Q37212257) (← links)
- Performing a percutaneous liver biopsy in parenchymal liver diseases (Q37282615) (← links)
- Noninvasive assessment of hepatic steatosis. (Q37360964) (← links)
- Update of liver fibrosis and steatosis with transient elastography (Fibroscan). (Q37615606) (← links)
- MR imaging of liver fibrosis: current state of the art. (Q37644144) (← links)
- The safety of same-day endoscopy and percutaneous liver biopsy. (Q37790637) (← links)
- Diagnostic laparoscopy in the cat: 1. Rationale and equipment (Q38173214) (← links)
- Endoscopic ultrasound-guided liver biopsy (Q38505618) (← links)
- Imaging-guided Parenchymal Liver Biopsy: How We Do It (Q38537850) (← links)
- Further exploration of MRI techniques for liver T1rho quantification (Q39276560) (← links)
- Treatment settings (Q40881609) (← links)
- Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable disease (Q40888760) (← links)